Niagara Pharmaceuticals Inc

Form 483

Dundas, -, CanadaFEI 3003093882Issued May 16, 2016

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3003093882.

Observations2

Issue DateMay 16, 2016

StatusNo Warning Letter

Related Inspections6

Establishment Details

Firm: Niagara Pharmaceuticals Inc
Location: Dundas, -, Canada
FEI Number: 3003093882
Product Type: Drugs
Issue Date: May 16, 2016
Country: Canada

Inspection History, 2010 to 2022

NAI2

VAI3

OAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Niagara Pharmaceuticals Inc FDA Form 483, Dundas, May 16, 2016